Inflammation and the metabolic syndrome: Clustering and impact on survival in a Swedish community-based cohort of 75 year olds

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 2, 2013, Pages 92-101

  Nilsson, Göran ^a,b   Hedberg, Pär ^a   Öhrvik, John ^c  

^a CENTRAL HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FACTORIAL ANALYSIS; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SURVIVAL; WAIST CIRCUMFERENCE;

AGED; BLOOD GLUCOSE; CHOLESTEROL, HDL; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; METABOLIC SYNDROME X; PRINCIPAL COMPONENT ANALYSIS; RISK FACTORS; SEX FACTORS; SWEDEN; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84876813189     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0100     Document Type: Article

References (35)

1. NCEP. Third report of the National Cholesterol Education Program (NCEP). NIH Publication, 2001, No 01-3670.
2. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
3. Ohrvik J, Hedberg P, Jonason T, et al. Factor analysis of the individual components of the metabolic syndrome among elderly identifies two factors with different survival patterns - A population-based study. Metab Syndr Relat Disord 2009;7:171-177.
4. Nieto FJ, SzkloM,Folsom AR,etal. Leukocyte count correlates in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992;136:525-537.
5. Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:455-461. (Pubitemid 34764803)
6. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
7. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391-397.
8. Madjid M, Awan I, Willerson JT, et al. Leukocyte count and coronary heart disease: Implications for risk assessment. J Am Coll Cardiol 2004;44:1945-1956. (Pubitemid 39473277)
9. Jee SH, Park JY, Kim HS, et al. White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans. Am J Epidemiol 2005;162:1062-1069.
10. Nilsson G, Hedberg P, Jonason T, et al. White blood cell counts associate more strongly to the metabolic syndrome in 75-year-old women than in men: A population based study. Metab Syndr Relat Disord 2007;5:359-364. (Pubitemid 350208899)
11. Kang YH, Min HG, Kim IJ, et al. Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: A study of Korean adults. Endocr J 2008;55:1093-1102.
12. Kim DJ, Noh JH, Lee BW, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci 2008;23:193-198.
13. Wang YY, Lin SY, Liu PH, et al. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications 2004;18:322-327.
14. Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008;38:502-509. (Pubitemid 351832033)
15. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis risk in communities study. Am J Epidemiol 2001;154:758-764. (Pubitemid 32971497)
16. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-508. (Pubitemid 40344380)
17. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69.
18. NCEP. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
19. Timmerman ME, Kiers HA, Smilde AK. Estimating confidence intervals for principal component loadings: A comparison between the bootstrap and asymptotic results. Br J Math Stat Psychol 2007;60(Pt 2):295-314.
20. Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: Extension to survival analysis. Stat Med 2011;30:22-38.
21. Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 2001;286:64-70. (Pubitemid 32606333)
22. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
23. Nilsson G, Hedberg P, Jonason T, et al. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Intern Med 2008;19:520-526.
24. Sakkinen PA, Wahl P, Cushman M, et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152:897-907.
25. Kahn SE, Zinman B, Haffner SM, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006;55:2357-2264.
26. Okosun IS. Metabolic syndrome and C-reactive protein in American adults: the impact of abdominal obesity. Metab Syndr Relat Disord 2008;6:289-297.
27. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119. (Pubitemid 40629025)
28. Lehto S, Ronnemaa T, Pyorala K, et al. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 2000;43:148-155. (Pubitemid 30126818)
29. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126. (Pubitemid 29054847)
30. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit. Am Heart J 2004;148(1 Suppl):S19-S26. (Pubitemid 38887094)
31. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252:283-294. (Pubitemid 35253696)
32. Grimm RH, Jr., Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA1985;254:1932-1937. (Pubitemid 15249094)
33. James AL, Knuiman MW, Divitini ML, et al. Associations between white blood cell count, lung function, respiratory illness and mortality: The Busselton Health Study. Eur Respir J 1999;13:1115-1119. (Pubitemid 29288938)
34. de Labry LO, Campion EW, Glynn RJ, et al. White blood cell countasa predictorofmortality: Results over 18years from the Normative Aging Study. J Clin Epidemiol 1990;43:153-157. (Pubitemid 20062807)
35. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499-503.